Global Electrostatic Live Cell Encapsulation Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Electrostatic Live Cell Encapsulation Market Research Report 2024
Live cell encapsulation has long been proposed as a solution to many therapeutic problems in modern medicine. Cell encapsulation technology is used to immobilise cells within biocompatible and semipermeable membranes. Encapsulation of cells, rather than therapeutic products, is used to allow the delivery of molecules of interest for a longer time period because cells release these molecules of interest continuously. Furthermore, cells can be engineered to express the desired protein in vivo without modifying the host's genome. Cell encapsulation has a significant advantage over protein encapsulation because it allows for the sustained and controlled delivery of therapeutic molecules at a constant rate, resulting in higher physiological concentrations.
According to MRAResearch’s new survey, global Electrostatic Live Cell Encapsulation market is projected to reach US$ 395.5 million in 2033, increasing from US$ 297 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Electrostatic Live Cell Encapsulation market research.
Key companies engaged in the Electrostatic Live Cell Encapsulation industry include ViaCyte, MIKROCAPS, Balchem Inc, Sernova Corp, Blacktrace Holdings Limited, Merck KGaA, BÜCHI Labortechnik AG, PharmaCyte Biotech and Living Cell Technologies Limited, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Electrostatic Live Cell Encapsulation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Electrostatic Live Cell Encapsulation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Electrostatic Live Cell Encapsulation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
ViaCyte
MIKROCAPS
Balchem Inc
Sernova Corp
Blacktrace Holdings Limited
Merck KGaA
BÜCHI Labortechnik AG
PharmaCyte Biotech
Living Cell Technologies Limited
Sigilon Therapeutics, Inc
Encapsys, LLC
Neurotech LLC
LycoRed Ltd
Beta-O2 Technologies Ltd
DuPont
Austrianova
Segment by Type
Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other
Pharmacy
Regenerative Medicine
Cell Transplantation
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Electrostatic Live Cell Encapsulation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Electrostatic Live Cell Encapsulation market is projected to reach US$ 395.5 million in 2033, increasing from US$ 297 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Electrostatic Live Cell Encapsulation market research.
Key companies engaged in the Electrostatic Live Cell Encapsulation industry include ViaCyte, MIKROCAPS, Balchem Inc, Sernova Corp, Blacktrace Holdings Limited, Merck KGaA, BÜCHI Labortechnik AG, PharmaCyte Biotech and Living Cell Technologies Limited, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Electrostatic Live Cell Encapsulation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Electrostatic Live Cell Encapsulation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Electrostatic Live Cell Encapsulation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ViaCyte
MIKROCAPS
Balchem Inc
Sernova Corp
Blacktrace Holdings Limited
Merck KGaA
BÜCHI Labortechnik AG
PharmaCyte Biotech
Living Cell Technologies Limited
Sigilon Therapeutics, Inc
Encapsys, LLC
Neurotech LLC
LycoRed Ltd
Beta-O2 Technologies Ltd
DuPont
Austrianova
Segment by Type
Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other
Segment by Application
Pharmacy
Regenerative Medicine
Cell Transplantation
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Electrostatic Live Cell Encapsulation report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source